Compare GRANULES INDIA with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GRANULES INDIA vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GRANULES INDIA AUROBINDO PHARMA GRANULES INDIA/
AUROBINDO PHARMA
 
P/E (TTM) x 15.3 6.8 226.0% View Chart
P/BV x 3.4 1.6 208.3% View Chart
Dividend Yield % 0.5 0.7 77.7%  

Financials

 GRANULES INDIA   AUROBINDO PHARMA
EQUITY SHARE DATA
    GRANULES INDIA
Mar-21
AUROBINDO PHARMA
Mar-21
GRANULES INDIA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs4381,023 42.8%   
Low Rs138333 41.4%   
Sales per share (Unadj.) Rs130.7422.8 30.9%  
Earnings per share (Unadj.) Rs22.292.0 24.1%  
Cash flow per share (Unadj.) Rs28.3110.0 25.7%  
Dividends per share (Unadj.) Rs1.504.00 37.5%  
Avg Dividend yield %0.50.6 88.3%  
Book value per share (Unadj.) Rs86.8374.3 23.2%  
Shares outstanding (eoy) m247.67585.94 42.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.21.6 137.4%   
Avg P/E ratio x13.07.4 176.1%  
P/CF ratio (eoy) x10.26.2 165.0%  
Price / Book Value ratio x3.31.8 183.0%  
Dividend payout %6.84.3 155.5%   
Avg Mkt Cap Rs m71,337397,398 18.0%   
No. of employees `000NANA-   
Total wages/salary Rs m3,24335,350 9.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m32,375247,746 13.1%  
Other income Rs m2693,809 7.1%   
Total revenues Rs m32,644251,555 13.0%   
Gross profit Rs m8,55281,480 10.5%  
Depreciation Rs m1,51510,554 14.4%   
Interest Rs m263745 35.3%   
Profit before tax Rs m7,04473,990 9.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,54920,098 7.7%   
Profit after tax Rs m5,49553,892 10.2%  
Gross profit margin %26.432.9 80.3%  
Effective tax rate %22.027.2 81.0%   
Net profit margin %17.021.8 78.0%  
BALANCE SHEET DATA
Current assets Rs m19,970198,235 10.1%   
Current liabilities Rs m11,731106,652 11.0%   
Net working cap to sales %25.437.0 68.8%  
Current ratio x1.71.9 91.6%  
Inventory Days Days1619 85.0%  
Debtors Days Days86352 1,671.9%  
Net fixed assets Rs m17,157135,778 12.6%   
Share capital Rs m248586 42.3%   
"Free" reserves Rs m21,262218,713 9.7%   
Net worth Rs m21,510219,299 9.8%   
Long term debt Rs m3,4111,684 202.6%   
Total assets Rs m37,127334,013 11.1%  
Interest coverage x27.8100.3 27.7%   
Debt to equity ratio x0.20 2,065.3%  
Sales to assets ratio x0.90.7 117.6%   
Return on assets %15.516.4 94.8%  
Return on equity %25.524.6 103.9%  
Return on capital %29.333.8 86.7%  
Exports to sales %81.953.8 152.3%   
Imports to sales %26.816.4 163.7%   
Exports (fob) Rs m26,528133,248 19.9%   
Imports (cif) Rs m8,69140,615 21.4%   
Fx inflow Rs m26,528133,248 19.9%   
Fx outflow Rs m8,69144,946 19.3%   
Net fx Rs m17,83788,302 20.2%   
CASH FLOW
From Operations Rs m4,32533,289 13.0%  
From Investments Rs m-2,7715,987 -46.3%  
From Financial Activity Rs m-2,993-13,648 21.9%  
Net Cashflow Rs m-1,44125,831 -5.6%  

Share Holding

Indian Promoters % 41.6 48.8 85.4%  
Foreign collaborators % 0.4 3.1 11.4%  
Indian inst/Mut Fund % 25.7 37.9 67.9%  
FIIs % 21.4 21.4 100.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 58.0 48.2 120.4%  
Shareholders   216,385 341,568 63.4%  
Pledged promoter(s) holding % 7.0 24.4 28.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GRANULES INDIA With:   SUN PHARMA    LUPIN    CIPLA    DR. REDDYS LAB    CADILA HEALTHCARE    



Today's Market

SGX Nifty Up 44 Points; Indicates Positive Opening for Indian Stock Markets(SGX Nifty)

The SGX Nifty opened on a positive note today. At 8:05 am, it was trading up by 44 points, or 0.3% higher at 17,148 levels.

Related Views on News

GRANULES INDIA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of GRANULES INDIA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of GRANULES INDIA. Also includes updates on the valuation of GRANULES INDIA.

AUROBINDO PHARMA Announces Quarterly Results (1QFY22); Net Profit Down 2.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (down 2.0% YoY). Sales on the other hand came in at Rs 57 bn (down 3.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

Aurobindo Pharma's Stock Falls After Profits Decline 7% (Views On News)

Jun 1, 2021

Aurobindo Pharma shares fell nearly 4% after quarterly earnings disappoint.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

Top Indian Drone Companies to Watch Out for in 2022(Views On News)

Jan 21, 2022

Several companies are adopting drone technology for regular business operations.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GRANULES INDIA SHARE PRICE


Jan 27, 2022 (Close)

TRACK GRANULES INDIA

  • Track your investment in GRANULES INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GRANULES INDIA

GRANULES INDIA - PARENT.DRUGS COMPARISON

COMPARE GRANULES INDIA WITH

MARKET STATS